Nutromics exists to save lives through continuous diagnostic monitoring. Current diagnostics offer only a delayed and limited snapshot of what is happening inside the body. We are changing that with the world’s first lab-on-a-patch®, a wearable device that delivers continuous, real-time molecular insights. Our platform technology uses AI-designed, DNA-based biosensors (aptamers) to track multiple critical molecular targets at once. This enables doctors to access real-time data on key markers, supporting faster decisions, more effective treatment, and better outcomes. Our first product focuses on the life-saving antibiotic vancomycin, with additional programs underway in sepsis, cardiology, and triage. Nutromics will eliminate the lag between symptom onset and diagnosis, providing doctors with immediate molecular data that helps prevent complications, reduce costs, and save lives.
| Website | https://www.nutromics.com |
| Revenue | $6.3 million |
| Employees | 62 (48 on RocketReach) |
| Founded | 2017 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Continuous Monitoring, Diagnostic Technology, Health Diagnostics, Wearable Biosensors, Medical Sensors, Health Monitoring, Biosensor Technology, Disease Detection, Diagnostic Devices, Biomedical Sensors, Digital Health, Personal Diagnostics, Point Of Care Diagnostics, Remote Patient Monitoring |
| Competitors | Medtronic, Abbott, Dexcom, Biosensors International Group, Ltd, OMRON Healthcare, Inc., Welldoc, MetaMap, SmartHealth, C8 MediSensors, Zeo, Inc. +29 more (view full list) |
Looking for a particular Nutromics employee's phone or email?
The Nutromics annual revenue was $6.3 million in 2026.
Peter Vranes is the CEO and Co-Founder of Nutromics.
48 people are employed at Nutromics.
Nutromics is based in Melbourne, Victoria.